产品名称
Phospho-Bcl-2 (S70) Recombinant Rabbit Monoclonal Antibody [PSH11-02] - BSA and Azide free
抗体类型
Recombinant Rabbit monoclonal Antibody
免疫原
Synthetic phospho-peptide corresponding to residues surrounding Ser70 of Human Bcl-2.
靶点分子量
Predicted band size: 26 kDa
阳性对照
Jurrkat treated with 1μM paclitaxel overnight cell lysate, Jurkat cells treated with 1μM paclitaxel overnight.
存放说明
Store at 2-8℃. Avoid freeze.
纯化方式
Protein A affinity purified.
功能
Bcl-2, encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins. BCL2 blocks programmed cell death (apoptosis) while other BCL2 family members can either inhibit or induce it. It was the first apoptosis regulator identified in any organism. Bcl-2 derives its name from B-cell lymphoma 2, as it is the second member of a range of proteins initially described in chromosomal translocations involving chromosomes 14 and 18 in follicular lymphomas. Orthologs (such as Bcl2 in mice) have been identified in numerous mammals for which complete genome data are available. Like BCL3, BCL5, BCL6, BCL7A, BCL9, and BCL10, it has clinical significance in lymphoma.
背景文献
1. Kaufman JL et al. Targeting BCL-2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma. Am J Hematol. 2021 Apr
2. Li X et al. Upregulation of BCL-2 by acridone derivative through gene promoter i-motif for alleviating liver damage of NAFLD/NASH. Nucleic Acids Res. 2020 Sep
亚细胞定位
Mitochondrion outer membrane, Nucleus membrane, Endoplasmic reticulum membrane, Cytoplasm.
别名
Apoptosis regulator Bcl 2 antibody
Apoptosis regulator Bcl-2 antibody
Apoptosis regulator Bcl2 antibody
AW986256 antibody
B cell CLL/lymphoma 2 antibody
B cell leukemia/lymphoma 2 antibody
Bcl-2 antibody
Bcl2 antibody
BCL2_HUMAN antibody
C430015F12Rik antibody
展开
Apoptosis regulator Bcl 2 antibody
Apoptosis regulator Bcl-2 antibody
Apoptosis regulator Bcl2 antibody
AW986256 antibody
B cell CLL/lymphoma 2 antibody
B cell leukemia/lymphoma 2 antibody
Bcl-2 antibody
Bcl2 antibody
BCL2_HUMAN antibody
C430015F12Rik antibody
D630044D05Rik antibody
D830018M01Rik antibody
Leukemia/lymphoma, B-cell, 2 antibody
Oncogene B-cell leukemia 2 antibody
PPP1R50 antibody
Protein phosphatase 1, regulatory subunit 50 antibody
Bcl 2 antibody
折叠
-
☑ Cell treatment (CT)
This data was developed using HA723269, the same antibody clone in a different buffer formulation.
Western blot analysis of Phospho-Bcl-2 (S70) on different lysates with Rabbit anti-Phospho-Bcl-2 (S70) antibody (HA723269) at 1/2,000 dilution.
Lane 1: Jurrkat cell lysate
Lane 2: Jurrkat treated with 1μM paclitaxel overnight cell lysate
Lane 3: Jurrkat treated with 1μM paclitaxel overnight cell lysate, then the membrane treated with λpp for 1 hour
Lysates/proteins at 20 µg/Lane.
Predicted band size: 26 kDa
Observed band size: 26 kDa
Exposure time: 1 minute 15 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA723269) at 1/2,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
-
☑ Cell treatment (CT)
This data was developed using HA723269, the same antibody clone in a different buffer formulation.
Immunocytochemistry analysis of Jurkat cells untreated / treated with 1μM paclitaxel overnight labeling Phospho-Bcl-2 (S70) with Rabbit anti-Phospho-Bcl-2 (S70) antibody (HA723269) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Phospho-Bcl-2 (S70) antibody (HA723269) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
-
☑ Cell treatment (CT)
This data was developed using HA723269, the same antibody clone in a different buffer formulation.
Flow cytometric analysis of untreated Jurkat cells (top) / Jurkat cells treated with 1μM paclitaxel overnight (bottom) labeling Phospho-Bcl-2 (S70).
Cells were fixed and permeabilized. Then stained with the primary antibody (HA723269, 1/10,000) (right) compared with Rabbit IgG Isotype Control (1μg/mL, left). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃.
请注意: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"